EUCTR2011-003264-77-NL进行中（未招募）不适用
A prospective trial with ketoconazole and octreotide combination therapy for treatment of Cushing’s disease. - Octreotide and ketoconazole for Cushing's disease
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- Erasmus MC
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Biochemically confirmed ACTH dependent Cushing's syndrome originating from a pituitary adenoma (either de novo, recurrent or residual)
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 10
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 10
排除标准
- •Impaired liver function
- •Renal insufficiency
- •Symptomatic cholelithiasis
- •History of pituitary irradiation
研究者
相似试验
已完成
2 期
A prospective trial with ketoconazole and octreotide combination therapy for treatment of Cushing*s disease.Cushing's diseasepituitary ACTH hypersecretion10021112NL-OMON36055Erasmus MC, Universitair Medisch Centrum Rotterdam10
招募中
不适用
Ketoconazole and octreotide as medical treatment for Cushing's disease.Cushing's diseaseZiekte van CushingNL-OMON20862Erasmus MC Rotterdam10
进行中（未招募）
不适用
Ketoconazole in Locally Advanced or Disseminated Granulosa Cell Tumour of Ovary.EUCTR2012-001948-21-ESGrupo Español de Tumores Huérfanos e Infrecuentes
已完成
3 期
Evaluation of the effectiveness of climbazole shampoo treatment.tinea versicolor.Pityriasis versicolorB36.0IRCT20190811044510N1Kerman University of Medical Sciences60
已完成
1 期
Effect of Ketoconazole on Regorafenib (BAY73-4506) PharmacokineticsPharmacokineticsNCT01318265Bayer24